Mechanism of action

GHK (glycyl-L-histidyl-L-lysine) binds copper(II) ions with high affinity, and most of its reported activity is attributed to this copper complex. No classical membrane receptor has been identified; the peptide appears to act through copper delivery into cells and broad modulation of gene transcription. Gene-expression analyses associate GHK with altered expression of a large number of human genes, including many involved in tissue remodeling and repair (Pickart & Margolina 2018). In vitro, GHK-Cu stimulates collagen synthesis in dermal fibroblast cultures (Maquart et al. 1988) and promotes production of glycosaminoglycans and other extracellular matrix components. In fibroblast cultures, GHK-Cu also increased MMP-2 expression and the secretion of the tissue inhibitors TIMP-1 and TIMP-2 (Siméon et al. 2000), which is discussed as a mechanism of wound remodeling in preclinical models. Antioxidant and anti-inflammatory effects have additionally been described in cell and animal studies.

State of evidence

The evidence base for GHK-Cu is predominantly preclinical, including fibroblast cultures, gene-expression analyses and animal wound models. Maquart et al. (1988) and Siméon et al. (2000) report cell-level observations on collagen and extracellular-matrix remodeling; the Pickart reviews from 2012, 2015 and 2018 synthesize literature rather than supply independent clinical confirmation. Limited controlled human evidence concerns topical skin care. In the randomized post-CO2-laser trial published in 2006, 13 patients completed follow-up with skin-care regimens with or without GHK-Cu. Erythema resolution did not differ significantly between groups; at twelve weeks, objective assessments of wrinkles and overall skin quality likewise found no significant between-group improvement. Patient-reported satisfaction was higher with the GHK-Cu regimen. This small study evaluates a particular topical regimen after laser resurfacing, not isolated systemic or injected GHK-Cu. The cited sources provide no reliable human systemic plasma half-life or controlled evidence supporting broad injectable efficacy or safety. Review hypotheses and preclinical mechanisms cannot resolve those gaps, and these scientific reports do not establish a particular research product's authorization or properties.

Questions about the research

What is GHK-Cu studied for in research?

GHK-Cu is studied mainly in skin and wound research, including collagen synthesis, extracellular-matrix remodeling and gene expression in repair processes. Most evidence comes from cell and animal models. A small controlled human study examined a topical skin-care regimen after CO2 laser resurfacing; its findings cannot be transferred to systemic or injected material.

What is the state of the evidence on GHK-Cu?

Preclinical evidence predominates, but a randomized topical post-laser study exists. It had 13 completers and found no significant group differences in erythema, wrinkles or objectively assessed skin quality, although subjective satisfaction was higher. This is limited early human evidence for a topical regimen, not support for broad clinical efficacy, systemic safety or research-product authorization.

Sources

1. Pickart and Margolina, Int J Mol Sci 2018, review of GHK-Cu biology and evidenceDOI: 10.3390/ijms19071987PMID: 29986520
2. Pickart et al., Oxid Med Cell Longev 2012, review of GHK and gene-expression findingsDOI: 10.1155/2012/324832PMID: 22666519
3. Pickart et al., BioMed Res Int 2015, review of GHK-related skin and wound researchDOI: 10.1155/2015/648108PMID: 26236730
4. Siméon et al., Life Sci 2000DOI: 10.1016/s0024-3205(00)00803-1PMID: 11045606
5. Maquart et al., FEBS Lett 1988DOI: 10.1016/0014-5793(88)80509-xPMID: 3169264
6. Pickart & Thaler, Nat New Biol 1973PMID: 4349963
7. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin, randomized topical trial, 2006DOI: 10.1001/archfaci.8.4.252PMID: 16847171

Mechanism of action

GHK (glycyl-L-histidyl-L-lysine) binds copper(II) ions with high affinity, and most of its reported activity is attributed to this copper complex. No classical membrane receptor has been identified; the peptide appears to act through copper delivery into cells and broad modulation of gene transcription. Gene-expression analyses associate GHK with altered expression of a large number of human genes, including many involved in tissue remodeling and repair (Pickart & Margolina 2018). In vitro, GHK-Cu stimulates collagen synthesis in dermal fibroblast cultures (Maquart et al. 1988) and promotes production of glycosaminoglycans and other extracellular matrix components. In fibroblast cultures, GHK-Cu also increased MMP-2 expression and the secretion of the tissue inhibitors TIMP-1 and TIMP-2 (Siméon et al. 2000), which is discussed as a mechanism of wound remodeling in preclinical models. Antioxidant and anti-inflammatory effects have additionally been described in cell and animal studies.

State of evidence

The evidence base for GHK-Cu is predominantly preclinical, including fibroblast cultures, gene-expression analyses and animal wound models. Maquart et al. (1988) and Siméon et al. (2000) report cell-level observations on collagen and extracellular-matrix remodeling; the Pickart reviews from 2012, 2015 and 2018 synthesize literature rather than supply independent clinical confirmation. Limited controlled human evidence concerns topical skin care. In the randomized post-CO2-laser trial published in 2006, 13 patients completed follow-up with skin-care regimens with or without GHK-Cu. Erythema resolution did not differ significantly between groups; at twelve weeks, objective assessments of wrinkles and overall skin quality likewise found no significant between-group improvement. Patient-reported satisfaction was higher with the GHK-Cu regimen. This small study evaluates a particular topical regimen after laser resurfacing, not isolated systemic or injected GHK-Cu. The cited sources provide no reliable human systemic plasma half-life or controlled evidence supporting broad injectable efficacy or safety. Review hypotheses and preclinical mechanisms cannot resolve those gaps, and these scientific reports do not establish a particular research product's authorization or properties.

Questions about the research

What is GHK-Cu studied for in research?

GHK-Cu is studied mainly in skin and wound research, including collagen synthesis, extracellular-matrix remodeling and gene expression in repair processes. Most evidence comes from cell and animal models. A small controlled human study examined a topical skin-care regimen after CO2 laser resurfacing; its findings cannot be transferred to systemic or injected material.

What is the state of the evidence on GHK-Cu?

Preclinical evidence predominates, but a randomized topical post-laser study exists. It had 13 completers and found no significant group differences in erythema, wrinkles or objectively assessed skin quality, although subjective satisfaction was higher. This is limited early human evidence for a topical regimen, not support for broad clinical efficacy, systemic safety or research-product authorization.

Sources

1. Pickart and Margolina, Int J Mol Sci 2018, review of GHK-Cu biology and evidenceDOI: 10.3390/ijms19071987PMID: 29986520
2. Pickart et al., Oxid Med Cell Longev 2012, review of GHK and gene-expression findingsDOI: 10.1155/2012/324832PMID: 22666519
3. Pickart et al., BioMed Res Int 2015, review of GHK-related skin and wound researchDOI: 10.1155/2015/648108PMID: 26236730
4. Siméon et al., Life Sci 2000DOI: 10.1016/s0024-3205(00)00803-1PMID: 11045606
5. Maquart et al., FEBS Lett 1988DOI: 10.1016/0014-5793(88)80509-xPMID: 3169264
6. Pickart & Thaler, Nat New Biol 1973PMID: 4349963
7. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin, randomized topical trial, 2006DOI: 10.1001/archfaci.8.4.252PMID: 16847171